Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Lung Inflammation Induced by Cannabis Smoke Regulated by Human Antigen R (HuR)

EF 2022-23

Résumé
Cannabis is the most commonly used illicit drug in the world, with an estimated 192 million users globally, and this number is suspected to increase drastically due to its widespread legalization as seen in Canada. The most common route of consumption is via inhalation of smoke. However, the inhaled smoke contains hundreds of chemicals such as carcinogens, tars, and other toxicants, similarly to tobacco smoke. The link between tobacco smoke consumption and adverse pulmonary health effects such as chronic inflammation causing chronic obstructive pulmonary disease (COPD) have already been demonstrated. However, there is a significant knowledge gap regarding whether cannabis smoke inhalation may pose a similar threat to lung health. We have previously demonstrated that cigarette smoke contributes to this lung inflammation via the human antigen receptor (HuR) protein. This protein does so by moving in the cell, causing an up-regulation of different factors that promote inflammation, and even cancer, in the lungs. Though, it has not yet been demonstrated if cannabis smoke provokes HuR in the same way as tobacco smoke. Therefore, the objective of this project is to assess how this protein moves in the cell in response to cannabis smoke, and determine if it is inducing an inflammatory response, or other harmful cellular processes, in the lungs. Despite the legalization of cannabis in Canada, the health consequences of inhaled cannabis are poorly characterized. Further research is vital to ensure the safety of the millions of Canadian consumers. Together, this project will provide significant contributions to our understanding of the safety of inhaled cannabis on our lungs.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486594
Name
Arlen Maddison T
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Lung Inflammation Induced by Cannabis Smoke Regulated by Human Antigen R (HuR)
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cannabinoids; Cannabis; Cell Signalling; Exposure; Human Antigen R; Inflammation; Lung Disease; Smoking
Abstract
Cannabis is the most commonly used illicit drug in the world, with an estimated 192 million users globally, and this number is suspected to increase drastically due to its widespread legalization as seen in Canada. The most common route of consumption is via inhalation of smoke. However, the inhaled smoke contains hundreds of chemicals such as carcinogens, tars, and other toxicants, similarly to tobacco smoke. The link between tobacco smoke consumption and adverse pulmonary health effects such as chronic inflammation causing chronic obstructive pulmonary disease (COPD) have already been demonstrated. However, there is a significant knowledge gap regarding whether cannabis smoke inhalation may pose a similar threat to lung health. We have previously demonstrated that cigarette smoke contributes to this lung inflammation via the human antigen receptor (HuR) protein. This protein does so by moving in the cell, causing an up-regulation of different factors that promote inflammation, and even cancer, in the lungs. Though, it has not yet been demonstrated if cannabis smoke provokes HuR in the same way as tobacco smoke. Therefore, the objective of this project is to assess how this protein moves in the cell in response to cannabis smoke, and determine if it is inducing an inflammatory response, or other harmful cellular processes, in the lungs. Despite the legalization of cannabis in Canada, the health consequences of inhaled cannabis are poorly characterized. Further research is vital to ensure the safety of the millions of Canadian consumers. Together, this project will provide significant contributions to our understanding of the safety of inhaled cannabis on our lungs.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Arlen, Maddison T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~